2026 POSTER PRESENTATIONS
Poster Awards will be announced Wednesday at 10:45 and Thursday at 10:55
POSTER SESSION A: Tuesday - Wednesday (morning)
A01: Custom Resin Services in Action: Illustrating an Affinity Resin Case Study, Presented by Yaiza L., Agarose Bead Technologies
A02: Developing Next Generation Multi-Attribute LC-MS Methods for Characterization of mRNA Critical Quality Attributes, Presented by Francesca H., AstraZeneca
A03: Inverted Flow Monolith Media for Purification of Large Plasmid DNA Required for Cell and Gene Therapy, Presented by Chervee H., BioChromatographix International
A04: Towards Intelligent Bioprocessing: Adaptive Strategies for Dynamic Nutrient Control, Presented by Liang Z., BioEngine
A05: Improving Large Biomolecule Purification Through DOE Studies and Advanced Resin Technologies, Presented by Jean-Francois D., Bio-Rad Laboratories
A06: Enhancing Purity of an Emtansine Biosimilar ADC Through Mixed-Mode Chromatography, Presented by Artur S., Bio-Rad Laboratories
A07: A Rapid Biochemical Surrogate for Allogeneic Cell Therapy Potency, Presented by Alexandra S., BlueRock Therapeutics
A08: Continuous Chromatography to Increase Throughput and Sustainability for Purification of Synthetic Oligos and Peptides, Presented by Giulio L., ChromaCon – A YMC Company
A09: Sustainable Compendial Grade GMP Detergent Substitutes for Triton™ X-100 in Bioprocessing Applications, Presented by James H., Croda Europe Ltd.
A10: Purity Matters: Multifunctional Roles of L-Arginine and L-Histidine in Bioprocessing and Formulation, Presented by Nuria MC., Croda Europe Ltd.
A11: End-to-End Manufacturing of Autologous CAR T Cell Therapies with the New Sefia™ Cell Therapy Manufacturing Platform, Presented by Francesca B., Cytiva
A12: A Scalable Downstream Process to Obtain Highly Pure Lentiviral Vectors for Next-Generation CAR T Therapies, Presented by Salete F., Cytiva
A13: Bioprocess Intensification with Peptide-Based Cell Culture Media Optimization Using Tyrosine and/or Cystine (Di)peptides, Presented by Sabrina M., Evonik Operations GmbH
A14: Unlocking the Potential of Virus-Based Therapies by Novel Cell Line Engineering Approaches, Presented by Agnes D., Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB)
A15: Automating Liquid Chromatography-Based N-Glycan Data Analysis for CMC Biologics Development, Presented by Begoña LA., Genedata AG
A16: Accelerating Biopharmaceutical CMC with NGS Technology through an AI-Driven and GMP-Compliant Digital Infrastructure, Presented by Sarah B., Genedata AG
A17: Unified, Scalable Workflow for Biotherapeutics Developability: Automated Assay Analytics from Discovery to CMC, Presented by Alexandre P., Genedata AG
A18: Overcoming Barriers to Adopting Protein A Membrane Affinity Technology by Demonstrating Capture Step Similarity, Presented by Feng G., W. L. Gore & Associates
A19: Enhancing CHO-M™ Cell Line Performance and Scalability Through the TranspoEase™ Platform, Presented by Amélie M., KBI Biopharma
A20: Process Development Driven by Smart Analytical Strategy, Presented by Živa R., Labena doo
A21: Precise and Flexible Formulation and Filling in End-to-End CAR-T Cell Manufacturing - The CliniMACS Prodigy TCTf Process, Presented by Sandro G., Miltenyi Biotec B.V. & CO. KG
A22: The Nanosyringe™ - A Novel Targeted, Intracellular Delivery Technology for Protein Therapeutics, Presented by Callum S., NanoSyrinx Ltd.
A23: DSP Strategies to Circumvent Liabilities Caused by CHO HCP, Presented by Aurélie B., Novartis Pharma AG
A24: Self-Removing Purification Tags Based on Split Inteins: A Promising Technology, Presented by Alexandra L., Novartis Pharma AG
A25: Increasing Throughput of Protein A Capture Using Variable Pathlength Technology (VPT), Presented by Anilkumar K., Repligen Europe B.V.
A26: Downstream Workflows for Intermediate Purification of Lentiviral Vectors Using Tangential Flow Filtration and AEX Membrane Chromatography, Presented by Sara C., Sartorius Stedim Biotech GmbH
A27: From Single Cell Cloning to Perfusion: Combined AI-Driven and Mechanistic Clone Selection Model for Cost Effective and Time-Efficient Cell Culture and Bioprocessing, Presented by Julia N., Sartorius Stedim Biotech GmbH
A28: Ambr® 250 High Throughput Generation 2: A New Standard for Small Scale Bioreactors, Presented by Ellen L., Sartorius Stedim Biotech Group, UK
A29: Next Generation Bioproduction: Advanced Engineering of a CHO Host Cell Line for Optimized Fed-Batch and Intensified Production, Presented by Kristin T., Sartorius Stedim Cellca GmbH
A30: Feed Smart, Scale Fast: Ambr 15–Driven Media–Feed Optimization and 2 L Bioreactor Comparison, Presented by Dennis K., Sartorius Xell GmbH
A31: Digital Modeling and Flow-Field Particle Image Analysis of a 5-L Bioreactor, Presented by Wei-Chun L., Taiwan Sugar Research Institute
A32: Optimization of a Wash Volume Reduction and Centrifugation Device for Standardized Mesenchymal Stem Cell (MSC) Manufacturing Process in a Bioreactor Environment, Presented by Beatriz M., Takeda
A33: Implementation of an Automated Water-Free Thawing Device in the Context of Manufacturing Process of a Commercial Cell Therapy Product, Presented by Raul V., Takeda
A34: Optimizing Protein-Cell Separation in Submerged Membrane Bioreactor for Clarification, Presented by Rebat K., Technical University of Denmark
A35: Towards Scalable Manufacturing of NK Cell from iPSCs, Presented by Gauri W., Technical University of Denmark
A36: Turning Data into Decisions for mAb Development and Production, Presented by Marco S., Thermo Fisher Scientific
A37: Synergies Within Pharma: Advancing BioPharma Workflows from R&D to Process to Patient, Presented by Angelo T., Thermo Fisher Scientific
A38: Advancing Biopharmaceutical Manufacturing Through Digital Twin Modelling of Mammalian Cell Culture Systems, Presented by Li Q., University College London
A39: Integrating Raman Spectroscopy and Genome-Scale Modeling to Enhance AAV Upstream Manufacturing, Presented by Itsasne A., Viralgen
A40: High Sensitivity Titer & Simplified 2D Protein A-SEC Analysis for Faster Quantitation of mAb Titers and Aggregates, Presented by Nick P., Waters UK Ltd.
A41: Speeding-Up Process Development of Mixed-Mode Chromatography with Mechanistic Modeling, Application to a Recombinant Protein, Presented by Edouard N., Ypso-Facto
POSTER SESSION B: Wednesday (afternoon) - Thursday
B01: Nuclease Choice as a Lever for Yield and Cost in Viral Vector Production, Presented by Jørn H., ArcticZymes
B02: Egr1 as a Potential Biomarker of Scale-Up-Induced Shear Stress in CHO Cell Culture mAb Production, Presented by Koki O., Astellas Pharma, Inc.
B03: Evaluating Viral Clearance in mAb Purification Using a Weak AEX-HIC Chromatography Resin, Presented by Evelyn S., Bio-Rad Laboratories
B04: Optimising rAAV Production for Intensified High Cell Density Processes, Presented by Rolando M., Cell and Gene Therapy Catapult
B05: Twin-Column Continuous Chromatography for Purification of Biologics, Presented by Thomas M., ChromaCon – A YMC Company
B06: Advancing Cell Dissociation in Bioprocessing with CellTrypase: A Novel, High-Purity Trypsin-Like Enzyme for GMP Workflows, Presented by Sedef OH., c-LEcta GmbH
B07: Viral Safety by Design: Addressing Unique Challenges in Cell and Gene Therapy Development, Presented by Loic P., INITS SMO
B08: Smart Technologies for Advanced Cell Line Development, Presented by Séverine F., KBI Biopharma
B09: Optimizing Detergent Use for AAV Recovery and Viral Inactivation in Gene Therapy Manufacturing, Presented by Clothilde D., Merck
B10: Perfusion Processing Leveraging Concentrated Medium and In-Line Dilution Using Modified Amino Acids, Presented by Lisa W., Merck
B11: Optimising rAAV Purification for Intensified High Cell Density Processes, Presented by Beata A., Pharmaron Biologics (UK) Ltd.
B12: The OneStream Refurbishment Project, Presented by Dominik M., Roche Diagnostics GmbH
B13: Sartobind® Rapid A Membrane Testing: Breaking the Speed Barrier, Presented by Mélanie M., Sanofi
B14: Novel Transfection Complex Stabilizer for Improved AAV Manufacturing Scalability and Efficiency, Presented by Cedric P., Sartorius Polyplus SAS
B15: Development of a Robust and Scalable AAV8 Production Platform: Enhancing Vector Yield and Purity Through Optimized Bioprocessing Techniques, Presented by Franziska B., Sartorius Stedim Biotech GmbH
B16: An Intensified N-1 Perfusion Process for High-Density Cultivation in the Biostat® RM with 4Cell® SmartCHO Cell Culture Medium, Presented by Paulo SG., Sartorius Stedim Biotech GmbH
B17: The Innovative Flow-Through Solution for Continuous Viral Inactivation, Presented by Stuart T., Sartorius Stedim Biotech GmbH
B18: Systematic Knockout of Host Cell Proteins for Efficient Biopharmaceutical Manufacturing, Presented by Ann-Cathrin L., Sartorius Stedim Cellca GmbH
B19: Process Solutions to Overcome High Cell Density Transfection Barriers in HEK293 Cells, Presented by Oliver H., Sartorius Xell GmbH
B20: CLD-401: A Next-Generation Systemic Gene Medicine for Tumor-Localized Expression of IL-15 Superagonist, Presented by Hongli Z., StemVac GmbH
B21: Evolution of Functional Fiber Harvest Technology: Past, Present, and Future, Presented by Monika D., Thermo Fisher Scientific
B22: Simultaneous Aggregate and High-Risk HCP Clearance Using Mixed-Mode Cation Exchange Chromatography in Flow-Through Mode, Presented by Carlos F., Thermo Fisher Scientific
B23: High Throughput Characterization of Subvisible Contamination in Protein Therapeutics, Presented by Ben W., Waters UK Ltd.
B24: Generalized Data Acquisition Parameters for Flow Imaging Microscopy to Streamline Quality Assessments of Injectable Biologics, Presented by Kendal S., Yokogawa Fluid Imaging Technologies, Inc.
B25: Beyond Conventional Analytics: Biophysical Strategies for mRNA Characterization, Presented by Natalia M., Biogardia AB
B26: Single-Use Tubular Bowl Centrifuges Enable Streamlined, Scalable, and High-Performance Recoveries Within an Automated Platform, Presented by Daniel N., CARR Biosystems
B27: The Impact of Elution pH on Product Quality of Fc-Containing Proteins, Presented by Alain M., Ecolab Life Sciences
B28: AI-Engineered NovoBody™-Based Probe for “High Capacity, Low Drift” BLI Analysis of His-Tagged Proteins, Presented by Benjamin O., Gator Bio
B29: Accelerating Small Scale Development in Gene Therapy: Fast and Robust Full Capsids Quantification Using Mass Photometry Technology from Refeyn (SamuxMP), Presented by Ricardo R., Généthon
B30: Magnetic Levitation Technology Used in Inline Dynamic Mixing Applications, Presented by Ramon C., Levitronix GmbH
B31: In-Line Monitoring of Downstream Processes Using Raman PAT Platform, Presented by Lenaig S., Merck
B32: Improving Perfusion Performance via Application of a Perfusion-Specific CLD Workflow in the CHOZN® Elite Cell Line, Presented by Guillaume R., Merck
B33: Enhancing Monoclonality Assurance in Cell Line Development: Seeing More at Day-0, Presented by Noud D., Nova Biomedical
B34: ReiCell-AAV: Development and Optimization of a Scalable High-Yield Suspension Cell Line for AAV Vector Manufacturing, Presented by Martina E., ReiThera Srl
B35: From GS KO to ADCC+: Expanding the CHOSOURCE™ Expression Platform for High-Potency Therapeutic Antibodies, Presented by Alex O., Revvity
B36: CHOSOURCE™ Transposon Technology: Enhancing Speed, Stability, and Productivity, Presented by Tulshi P., Revvity
B37: Enhancing Protein Purity Analysis Using CE-SDS with Native Fluorescence Detection on the BioPhase 8800 System, Presented by Stephen L., SCIEX
B38: Synthetic Transcriptional Hub Vectorology for CHO Cell Engineering, Presented by Andy R., SynGenSys Ltd.
B39: Smart Integration of MCC for a Sustainable Downstream Future, Presented by Sebastian T., Tosoh Bioscience GmbH
B40: Towards Hyper Intensification: Integrated and Intensified Downstream Processing on a Single Device, Presented by Presented by Carsten-René A., Tosoh Bioscience GmbH
B41: High Performance Resin for Larger Biomolecules such as AAVs and pDNA, Presented by Elena R., YMC Europe GmbH
ADDITIONAL VIRTUAL POSTERS
V1: Optimization of SEC-MALS Measurements for Biomolecule Analysis, Presented by Leonardo V., Tosoh Bioscience GmbH